Synergistic combinations of multiple chemotherapeutic agents in high capacity poly(2-oxazoline) micelles

Molecular Pharmaceutics

Volumn 9, Issue 8, 2012, Pages 2302-2313

  Han, Yingchao ^a,b   He, Zhijian ^a   Schulz, Anita ^c   Bronich, Tatiana K ^a   Jordan, Rainer ^c   Luxenhofer, Robert ^a,c   Kabanov, Alexander V ^a,d  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b WUHAN UNIVERSITY OF TECHNOLOGY   (China)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

block copolymer; combination therapy; drug delivery; drug formulation; nanomedicine; polymeric micelles; synergistic cytotoxicity

Indexed keywords

AMPHOPHILE; BORTEZOMIB; DOCETAXEL; DRUG CARRIER; ETOPOSIDE; OXAZOLINE DERIVATIVE; PACLITAXEL; POLY(2 OXAZOLINE); POLYMER; TANESPIMYCIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN MCF 7; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG POTENTIATION; DRUG RELEASE; DRUG STABILITY; HUMAN; HUMAN CELL; INTERNALIZATION; MICELLE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BENZOQUINONES; CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ETOPOSIDE; HEP G2 CELLS; HUMANS; LACTAMS, MACROCYCLIC; MICELLES; OXAZOLES; TAXOIDS;

EID: 84864650589     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300159u     Document Type: Article

References (61)

1. Persidis, A. Cancer multidrug resistance Nat. Biotechnol. 1999, 17, 94-95 (Pubitemid 29037219)
2. Clarke, M. F.; Fuller, M. Stem cells and cancer: two faces of Eve Cell 2006, 124, 1111-1115
3. Reya, T.; Morrison, S. J.; Clarke, M. F.; Weissman, I. L. Stem cells, cancer, and cancer stem cells Nature 2001, 414, 105-111 (Pubitemid 33041634)
4. Lapidot, T.; Sirard, C.; Vormoor, J.; Murdoch, B.; Hoang, T.; Caceres-Cortes, J.; Minden, M.; Paterson, B.; Caligiuri, M. A.; Dick, J. E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Nature 1994, 367, 645-648 (Pubitemid 24067706)
5. Al-Hajj, M.; Wicha, M. S.; Benito-Hernandez, A.; Morrison, S. J.; Clarke, M. F. Prospective identification of tumorigenic breast cancer cells Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 3983-3988 (Pubitemid 36418143)
6. Ramaswamy, S. Rational design of cancer-drug combinations N. Engl. J. Med. 2007, 357, 299-300 (Pubitemid 47080397)
7. Mayer, L. D.; Janoff, A. S. Optimizing combination chemotherapy by controlling drug ratios Mol. Interventions 2007, 7, 216-223 (Pubitemid 47437268)
8. Reddy, N.; Czuczman, M. S. Enhancing activity and overcoming chemoresistance in hematologic malignancies with bortezomib: preclinical mechanistic studies Ann. Oncol. 2010, 21, 1756-1764
9. Xiao, L.; Rasouli, P.; Ruden, D. M. Possible effects of early treatments of Hsp90 inhibitors on preventing the evolution of drug resistance to other anti-cancer drugs Curr. Med. Chem. 2007, 14, 223-232 (Pubitemid 46043917)
10. Zhao, M. D.; Hu, F. Q.; Du, Y. Z.; Yuan, H.; Chen, F. Y.; Lou, Y. M.; Yu, H. Y. Coadministration of glycolipid-like micelles loading cytotoxic drug with different action site for efficient cancer chemotherapy Nanotechnology 2009, 20, 055102
11. Song, X.; Zhao, Y.; Wu, W.; Bi, Y.; Cai, Z.; Chen, Q.; Li, Y.; Hou, S. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: Systematic study of particle size and drug entrapment efficiency Int. J. Pharm. 2008, 35, 320-329 (Pubitemid 351146679)
12. Wong, M.-Y.; Chiu, G. N. C. Simultaneous liposomal delivery of quercetin and vincristine for enhanced estrogen-receptor-negative breast cancer treatment Anti-Cancer Drugs 2010, 21, 401-410
13. Shin, H. C.; Alani, A. W. G.; Rao, D. A.; Rockich, N. C.; Kwon, G. S. Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs J. Controlled Release 2009, 140, 294-300
14. Luxenhofer, R.; Schulz, A.; Roques, C.; Li, S.; Bronich, T. K.; Batrakova, E. V.; Jordan, R.; Kabanov, A. V. Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drug Biomaterials 2010, 31, 4972-4979
15. Gelderblom, H.; Verweij, J.; Nooter, K.; Sparreboom, A. Cremophor EL: The drawbacks and advantages of vehicle selection for drug formulation Eur. J. Cancer 2001, 37, 1590-1598 (Pubitemid 32778603)
16. Hennenfent, K. L.; Govindan, R. Novel formulations of taxanes: a review. Old wine in a new bottle? Ann. Oncol. 2006, 17, 735-749
17. Weiss, R.; Donehower, R.; Wiernik, P.; Ohnuma, T.; Gralla, R.; Trump, D.; Baker, J., Jr.; Van Echo, D.; Von Hoff, D.; Leyland-Jones, B. Hypersensitivity reactions from taxol J. Clin. Oncol. 1990, 8, 1263-1268 (Pubitemid 20195638)
18. Barz, M.; Luxenhofer, R.; Zentel, R.; Vicent, M. J. Overcoming the PEG Addiction: well-defined alternatives to PEG, from structure-property relationships to better defined therapeutics Polym. Chem. 2011, 2, 1900-1918
19. Luxenhofer, R.; Han, Y.; Schulz, A.; Tong, J.; He, Z.; Kabanov, A. V. Poly(2-oxazoline)s as polymer therapeutics Macromol. Rapid Commun. 2012, 10.1002/marc.201200354
20. Rehfeldt, F.; Tanaka, M.; Pagnoni, L.; Jordan, R. Static and dynamic swelling of grafted poly(2-alkyl-2-oxazoline)s Langmuir 2002, 18, 4908-4914 (Pubitemid 35383566)
21. Viegas, T. X.; Bentley, M. D.; Harris, J. M.; Fang, Z.; Yoon, K.; Dizman, B.; Weimer, R.; Mero, A.; Pasut, G.; Veronese, F. M. Polyoxazoline: Chemistry, properties, and applications in drug delivery Bioconjugate Chem. 2011, 22, 976-986
22. Foreman, M. B.; Coffman, J. P.; Murcia, M. J.; Cesana, S.; Jordan, R.; Smith, G. S.; Naumann, C. A. Gelation of amphiphilic lipopolymers at the air-water interface: 2D analogue to 3D gelation of colloidal systems with grafted polymer chains? Langmuir 2003, 19, 326-332
23. Lin, P.; Clash, C.; Pearce, E. M.; Kwei, T. K.; Aponte, M. A. Solubility and miscibility of poly(ethyl oxazoline) J. Polym. Sci., Part B: Polym. Phys. 1988, 26, 603-619
24. Chen, F. P.; Ames, A. E.; Taylor, L. D. Aqueous solutions of poly(ethyloxazoline) and its lower consolute phase transition Macromolecules 1990, 23, 4688-4695
25. Zalipsky, S.; Hansen, C. B.; Oaks, J. M.; Allen, T. M. Evaluation of blood clearance rates and biodistribution of poly (2-oxazoline)-grafted liposomes J. Pharm. Sci. 1996, 85, 133-137
26. Woodle, M. C.; Engbers, C. M.; Zalipsky, S. New amphipatic polymerelipid conjugates forming long-circulating reticuloendothelial system-evading liposomes Bioconjugate Chem. 1994, 5, 493-496
27. Gaertner, F. C.; Luxenhofer, R.; Blechert, B.; Jordan, R.; Essler, M. Synthesis, biodistribution and excretion of radiolabeled poly(2-alkyl-2- oxazoline)s J. Controlled Release 2007, 119, 291-300 (Pubitemid 46770877)
28. Huber, S.; Jordan, R. Modulation of the lower critical solution temperature of 2-alkyl-2-oxazoline copolymers Colloid Polym. Sci. 2008, 286, 395-402
29. Park, J. S.; Kataoka, K. Comprehensive and accurate control of thermosensitivity of poly (2-alkyl-2-oxazoline)s via well-defined gradient or random copolymerization Macromolecules 2007, 40, 3599-3609 (Pubitemid 46841916)
30. Luxenhofer, R.; Sahay, G.; Schulz, A.; Alakhova, D.; Bronich, T. K.; Jordan, R.; Kabanov, A. V. Structure-property relationship in cytotoxicity and cell uptake of poly(2-oxazoline) amphiphiles J. Controlled Release 2011, 153, 73-82
31. Chou, T.-C. Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies Pharmacol. Rev. 2006, 58, 621-681 (Pubitemid 44403686)
32. Sain, N.; Krishnan, B.; Ormerod, M. G.; De Rienzo, A.; Liu, W. M.; Kaye, S. B.; Workman, P.; Jackman, A. L. Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT Mol. Cancer Ther. 2006, 5, 1197-1208 (Pubitemid 43881312)
33. Liggins, R. T.; Hunter, W. L.; Burt, H. M. Solid-state characterization of paclitaxel J. Pharm. Sci. 2000, 86, 1458-1463 (Pubitemid 28018330)
34. Development Therapeutics Program of the National Cancer Institute, Geldanamycin analogs. Bethesda, MD: Development Therapeutics Program of the National Cancer Institute. 2007, http://dtp.nci.nih.gov/timeline/posters/AGG- Geldamycin.pdf.
35. Material safety data sheet for Bortezomib. Revision date: May 20, 2009. LC laboratories.
36. Solomatin, S. V.; Bronich, T. K.; Bargar, T. W.; Eisenberg, A.; Kabanov, V. A.; Kabanov, A. V. Environmentally responsive nanoparticles from block ionomer complexes: Effects of pH and ionic strength Langmuir 2003, 19, 8069-8076
37. Shin, H. C.; Alani, A. W. G.; Cho, H.; Bae, Y.; Kolesar, J. M.; Kwon, G. S. A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs Mol. Pharmaceutics 2011, 8, 1257-1265
38. Kabanov, A. V.; Chekhonin, V. P.; Alakhov, V. Y.; Batrakova, E. V.; Lebedev, A. S.; Melik-Nubarov, N. S.; Arzhakov, S. A.; Levashov, A. V.; Morozov, G. V.; Severin, E. S.; Kabanov, V. A. The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting FEBS Lett. 1989, 258, 343-345 (Pubitemid 20001084)
39. Duncan, R. The dawning era of polymer therapeutics Nat. Rev. Drug Discovery 2011, 2, 347-360
40. Aryal, S.; Hu, C.-M. J.; Zhang, L. Combinatorial drug conjugation enables nanoparticle dual-drug delivery Small 2010, 6, 1442-1448
41. ABRAXIS BIOSCIENCE, ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension), U.S. Food and Drug Administration, http://www.accessdata.fda.gov/drugsatfda-docs/label/2008/ 021660s013lbl.pdf.
42. Solit, D. B.; Ivy, S. P.; Kopil, C.; Sikorski, R.; Morris, M. J.; Slovin, S. F.; Kelly, W. K.; DeLaCruz, A.; Curley, T.; Heller, G.; Larson, S.; Schwartz, L.; Egorin, M. J.; Rosen, N.; Scher, H. I. Phase I trial of 17-Allylamino-17-Demethoxygeldanamycin in patients with advanced cancer Clin. Cancer Res. 2007, 13, 1775-1782 (Pubitemid 46952945)
43. Grem, J. L.; Morrison, G.; Guo, X. D.; Agnew, E.; Takimoto, C. H.; Thomas, R.; Szabo, E.; Grochow, L.; Grollman, F.; Hamilton, J. M.; Neckers, L.; Wilson, R. H. Phase I and pharmacologic study of 17-(allylamino)-17- demethoxygeldanamycin in adult patients with solid tumors J. Clin. Oncol. 2005, 23, 1885-1893 (Pubitemid 46211366)
44. Solit, D. B.; Osman, I.; Polsky, D.; Panageas, K. S.; Daud, A.; Goydos, J. S.; Teitcher, J.; Wolchok, J. D.; Germino, F. J.; Krown, S. E.; Coit, D.; Rosen, N.; Chapman, P. B. Phase II trial of 17-allylamino-17-demethoxy- geldanamycin in patients with metastatic melanoma Clin. Cancer Res. 2008, 14, 8302-8307
45. Hande, K. R. Etoposide: four decades of development of a topoisomerase II inhibitor Eur. J. Cancer 1998, 34, 1514-1521 (Pubitemid 28446331)
46. Kobayashi, S. Ethylenimine polymers Prog. Polym. Sci. 1990, 15, 751-823
47. Mayer, L. D.; Harasym, T. O.; Tardi, P. G.; Harasym, N. L.; Shew, C. R.; Johnstone, S. A.; Ramsay, E. C.; Bally, M. B.; Janoff, A. S. Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice Mol. Cancer Ther. 2006, 5, 1854-1863 (Pubitemid 44323254)
48. Ramanathan, R. K.; Egorin, M. J.; Eiseman, J. L.; Ramalingam, S.; Friedland, D.; Agarwala, S. S.; Ivy, S. P.; Potter, D. M.; Chatta, G.; Zuhowski, E. G.; Stoller, R. G.; Naret, C.; Guo, J.; Belani, C. P. Phase I and pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with refractory advanced cancers Clin. Cancer Res. 2007, 13, 1769-1774 (Pubitemid 46952944)
49. Nguyen, D. M.; Lorang, D.; Chen, G. A.; Stewart, J. H., IV; Tabibi, E.; Schrump, D. S. Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: In vitro and in vivo analysis Ann. Thorac. Surg. 2001, 72, 371-379 (Pubitemid 32727130)
50. Yao, Q.; Weigel, B.; Kersey, J. Synergism between etoposide and 17-AAG in leukemia cells: critical roles for hsp90, FLT3, topoisomerase II, chk1, and rad51 Clin. Cancer Res. 2007, 13, 1591-1600 (Pubitemid 46450452)
51. Adams, J. The proteasome: a suitable antineoplastic target Nat. Rev. Cancer 2004, 4, 349-360 (Pubitemid 38579481)
52. Teicher, B. A.; Ara, G.; Herbst, R.; Palombella, V. J.; Adams, J. The proteasome inhibitor PS-341 in cancer therapy Clin. Cancer Res. 1999, 5, 2638-2645 (Pubitemid 29437352)
53. Mimnaugh, E. G.; Xu, W.; Vos, M.; Yuan, X.; Isaacs, J. S.; Bisht, K. S.; Gius, D.; Neckers, L. Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity Mol. Cancer Ther. 2004, 3, 551-566 (Pubitemid 39193734)
54. Luxenhofer, R.; Jordan, R. Click chemistry with poly (2-oxazoline)s Macromolecules 2006, 39, 3509-3516
55. Baekmark, T. R.; Sprenger, I.; Ruile, M.; Nuyken, O.; Merkel, R. Compression-induced formation of surface micelles in monolayers of a poly(2-oxazoline) diblock copolymer at the air-water interface: A combined film balance and electron microscopy study Langmuir 1998, 14, 4222-4226 (Pubitemid 128624890)
56. Bonne, T. B.; Lüdtke, K.; Jordan, R.; Stepanek, P.; Papadakis, C. M. Aggregation behavior of amphiphilic poly(2-alkyl-2-oxazoline) diblock copolymers in aqueous solution studied by fluorescence correlation spectroscopy Colloid Polym. Sci. 2004, 282, 833-843 (Pubitemid 38886059)
57. Bonne, T. B.; Lüdtke, K.; Jordan, R.; Papadakis, C. M. Effect of polymer architecture of amphiphilic poly(2-oxazoline) copolymers on the aggregation and aggregate structure Macromol. Chem. Phys. 2007, 201, 1402-1408 (Pubitemid 47252144)
58. Papadakis, C. M.; Ivanova, R.; Lüdtke, K.; Mortensen, K.; Pranzas, P. K.; Jordan, R. Micellar structure of amphiphilic poly(2-oxazoline) diblock copolymers J. Appl. Crystallogr. 2007, 40, 361-362
59. Ivanova, R.; Komenda, T.; Bonne, T. B.; Lüdtke, K.; Mortensen, K.; Pranzas, P. K.; Jordan, R.; Papadakis, C. M. Micellar structures of hydrophilic-lipophilic and hydrophilic-fluorophilic poly(2-oxazoline) diblock copolymers in water Macromol. Chem. Phys. 2008, 209, 2248-2258
60. Hoogenboom, R.; Wiesbrock, F.; Leenen, M. A. M.; Thijs, H. M. L.; Huang, H. Y.; Fustin, C. A.; Guillet, P.; Gohy, J. F.; Schubert, U. S. Synthesis and aqueous micellization of amphiphilic tetrablock ter- and quarterpoly(2- oxazoline)s Macromolecules 2007, 40, 2837-2843 (Pubitemid 46686435)
61. Fustin, C. A.; Lefevre, V.; Hoogenboom, R.; Schubert, U. S.; Gohy, J. F. Micellization of poly(2-oxazoline)based quasi-diblock copolymers on surfaces Macromol. Chem. Phys. 2007, 208, 2026-2031 (Pubitemid 47509989)